MRI前列腺复发影像报告评估评分的诊断准确性与观察者一致性
这项回顾性观察研究纳入100例根治性治疗后生化复发的患者,由四名放射科医生独立赋值PI-RR评分。以PI-RR≥3为 cutoff,放疗后灵敏度71%-81%、特异度74%-93%,根治性前列腺切除术后灵敏度59%-83%、特异度87%-100%,四名读者组内相关系数为0.87。
要点
- PI-RR评分以≥3为 cutoff 时,放疗后诊断准确度77%-88%,根治性前列腺切除术后75%-85%。
- 四名读者间组内相关系数为0.87,提示PI-RR评分具有良好可重复性。
- 放疗后特异度74%-93%,根治性前列腺切除术后特异度87%-100%,后者特异度范围更高。
核心结论
- PI-RR评估评分对前列腺癌根治性治疗后局部复发的MRI评价具有结构化、可重复且准确的特点。
研究设计与样本
- 回顾性观察研究,纳入2016年9月至2021年5月间因放疗或根治性前列腺切除术后生化复发而行多参数MRI的患者共100例。
- 放疗后组48例,中位年龄76岁(IQR 70-82岁);根治性前列腺切除术后组52例,中位年龄70岁(IQR 66-74岁)。
- MRI扫描由四名放射科医生独立分析并赋值PI-RR评分。
- 参考标准为组织病理学 findings、随访影像或对治疗的临床反应。
诊断标准与关键数值
- 放疗后组以PI-RR≥3为 cutoff(复发不确定时赋值),四名读者间灵敏度71%-81%、特异度74%-93%、阳性预测值71%-89%、阴性预测值79%-86%、准确度77%-88%。
- 根治性前列腺切除术后组以PI-RR≥3为 cutoff,四名读者间灵敏度59%-83%、特异度87%-100%、阳性预测值88%-100%、阴性预测值66%-80%、准确度75%-85%。
- 四名读者间组内相关系数在放疗后组和根治性前列腺切除术后组均为0.87。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Prostate cancer local recurrence location and extent must be determined in an accurate and timely manner. Because of the lack of a standardized MRI approach after whole-gland treatment, a panel of international experts recently proposed the Prostate Imaging for Recurrence Reporting (PI-RR) assessment score. Purpose To determine the diagnostic accuracy of PI-RR for detecting local recurrence in patients with biochemical recurrence (BCR) after radiation therapy (RT) or radical prostatectomy (RP) and to evaluate the interreader variability of PI-RR scoring. Materials and Methods This retrospective observational study included patients who underwent multiparametric MRI between September 2016 and May 2021 for BCR after RT or RP. MRI scans were analyzed, and a PI-RR score was assigned independently by four radiologists. The reference standard was defined using histopathologic findings, follow-up imaging, or clinical response to treatment. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated to assess PI-RR performance for each reader. The intraclass correlation coefficient was used to determine interreader agreement. Results A total of 100 men were included: 48 patients after RT (median age, 76 years [IQR, 70-82 years]) and 52 patients after RP (median age, 70 years [IQR, 66-74 years]). After RT, with PI-RR of 3 or greater as a cutoff (assigned when recurrence is uncertain), diagnostic performance ranges were 71%-81% sensitivity, 74%-93% specificity, 71%-89% PPV, 79%-86% NPV, and 77%-88% accuracy across the four readers. After RP, with PI-RR of 3 or greater as a cutoff, performance ranges were 59%-83% sensitivity, 87%-100% specificity, 88%-100% PPV, 66%-80% NPV, and 75%-85% accuracy. The intraclass correlation coefficient was 0.87 across the four readers for both the RT and RP groups. Conclusion MRI scoring with the Prostate Imaging for Recurrence Reporting assessment provides structured, reproducible, and accurate evaluation of local recurrence after definitive therapy for prostate cancer. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Haider in this issue. An earlier incorrect version appeared online. This article was corrected on May 11, 2022.
引用
- Pecoraro, Turkbey, Purysko, et al. Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score. Radiology. 2022. PMID: 35536130. doi:10.1148/radiol.212252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。